- organizations:Bausch + Lomb
Business
Bausch + Lomb names leading ophthalmologist as strategic medical advisor
Industry veteran Cathleen McCabe, MD, will consult on the company’s expanding product portfolio and serve as liaison to the global ECP community.
Products
FDA approves Bausch + Lomb's en Vista Envy IOL
Offering a continuous range of vision with excellent dysphotopsia tolerance, the lens will be initially available on a limited basis.
Products
Bausch + Lomb launches new digital ordering marketplace
The Opal e-commerce platform enables patients to directly order contact lens products from a customized catalog, freeing up clinical practice staff time and resources.
Products
FDA grants tentative approval for Lupin's Lumify generic eye drops
Brimonidine tartrate ophthalmic solution, 0.025% is indicated to treat ocular redness due to minor irritations in the eye.
Research
Pivotal study supports B+L's TENEO laser for myopic LASIK surgery
Pivotal 9-month study on the FDA-approved excimer laser platform reports 97.8% and 100% of eyes achieving UCDVA and CDVA of 20/25 or better.
Research
AREDS supplements may slow late-stage dry AMD progression
NEI-supported analysis identifies significant benefits based on new data from the AREDS and AREDS2 studies.
Business
Bausch + Lomb acquires Trukera Medical
Purchase of the former TearLab Corporation includes the ScoutPro Osmolarity System, a point-of-care portable device for osmolarity testing.
Research
Bausch + Lomb reports national dry eye data, launches awareness tool
State of the Dry Eye survey finds 70% of patients lack knowledge and education of the disease.
Products
Zenni Optical now offers contact lens ordering of top brands
New prescription-based orders feature CooperVision and Bausch + Lomb lenses.
Products
Bausch + Lomb to launch INFUSE for Astigmatism SiHy lenses in the US
Latest one-day silicone hydrogel lens addition maintains 96% of moisture for 16 hours.
Products
Bausch + Lomb launches Blink NutriTears for dry eye
Newest addition to the Blink product line targets root cause of disease; clinically proven to provide symptom relief in as little as 2 weeks.
Products
Bausch + Lomb's enVista Envy IOL secures Canadian approval
Acceptance marks first global regulatory approval for the new lens; company notes FDA approval is pending.
Products
Bausch + Lomb's Zenlens ECHO scleral lens launches in the US
Latest installment is designed as a non-prosthetic, custom scleral contact lens technology designed to fit a wide variety of corneal shapes and sizes.
Products
Bausch + Lomb reports statistically significant data on novel dry eye supplement
Randomized study suggests Blink NutriTears may restore tear film homeostasis by addressing DED’s key root causes.
Events
Eye safety tips you need to know ahead of the solar eclipse
Leading eyecare organizations and clinical experts offer their professional advice for safely watching this year’s big event on April 8.
Products
FDA issues warning against unapproved B+L copycat eye drops
Sample testing has identified bacterial contamination from products falsely marketed as a generic formulation of LUMIFY eye drops.
Events
Bausch + Lomb and GRF launch glaucoma awareness campaign
Glaucoma Research Foundation partners on patient-targeted initiative to honor January as Glaucoma Awareness Month.
Products
FDA approves Bausch+ Lomb’s TENEO excimer laser platform
Now considered the smallest excimer laser by footprint in the U.S., it’s designed for LASIK surgery in patients with myopia and myopic astigmatism.
Products
XIPERE earns Category 1 CPT code from AMA
FDA-approved therapeutic is the first and only to incorporate the suprachoroidal space to treat macular edema associated with uveitis.
Research